crizotinib

The drug is prescribed for adults for the treatment of advanced non-small cell lung cancer (both ALK-positive and ROS1-positive), as well as for children (from 2 to 18 years old) for the treatment of certain types of lymphoma (ALK+ diffuse large B-cell lymphoma) and tumors (anaplastic large cell lymphoma) that are ALK-positive.

Form: capsules

ATC: L01ED01

Manufacturer: Pfizer Manufacturing Deutschland GmbH

The drug is used for the treatment of adults with advanced non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It is also indicated for the treatment of children (aged 6 to 18 years) with certain types of lymphoma (ALCL) or tumors (SMT) that are ALK-positive.

Form: capsules

ATC: L01ED01

Manufacturer: Pfizer Manufacturing Deutschland GmbH